| 英文名 | 3-(4-{[4-(2-Oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1-piperidinyl]m ethyl}phenyl)-2-phenyl-6-quinoxalinecarboxylic acid |
|---|---|
| 英文别名 |
3-(4-{[4-(2-Oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1-piperidinyl]methyl}phenyl)-2-phenyl-6-quinoxalinecarboxylic acid
3-(4-{[4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]methyl}phenyl)-2-phenylquinoxaline-6-carboxylic acid 3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl}-phenyl)-(2E)-2-propenoic acid methyl ester (E)-Methyl 3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)acrylate 6-Quinoxalinecarboxylic acid, 3-[4-[[4-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]methyl]phenyl]-2-phenyl- |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 分子式 | C34H29N5O3 |
| 分子量 | 555.626 |
| 精确质量 | 555.227051 |
| PSA | 104.37000 |
| LogP | 5.66 |
| 折射率 | 1.698 |
|
~%
612847-29-7 |
| 文献：Lindsley, Craig W.; Zhao, Zhijian; Leister, William H.; Robinson, Ronald G.; Barnett, Stanley F.; Defeo-Jones, Deborah; Jones, Raymond E.; Hartman, George D.; Huff, Joel R.; Huber, Hans E.; Duggan, Mark E. Bioorganic and Medicinal Chemistry Letters, 2005 , vol. 15, # 3 p. 761 - 764 |
|
~%
612847-29-7 |
| 文献：Lindsley, Craig W.; Zhao, Zhijian; Leister, William H.; Robinson, Ronald G.; Barnett, Stanley F.; Defeo-Jones, Deborah; Jones, Raymond E.; Hartman, George D.; Huff, Joel R.; Huber, Hans E.; Duggan, Mark E. Bioorganic and Medicinal Chemistry Letters, 2005 , vol. 15, # 3 p. 761 - 764 |
|
~%
612847-29-7 |
| 文献：Lindsley, Craig W.; Zhao, Zhijian; Leister, William H.; Robinson, Ronald G.; Barnett, Stanley F.; Defeo-Jones, Deborah; Jones, Raymond E.; Hartman, George D.; Huff, Joel R.; Huber, Hans E.; Duggan, Mark E. Bioorganic and Medicinal Chemistry Letters, 2005 , vol. 15, # 3 p. 761 - 764 |
| 上游产品 4 | |
|---|---|
| 下游产品 0 | |
